Allahabadi family crest — Honour, Loyalty, Legacy
Evidence-Based Oncosurgery

Technological Advances in Surgical Oncology

Surgical precision directly drives oncological radicality and quality of survival. Below is how robotic platforms, real-time molecular imaging, and minimally invasive techniques have transformed clinical cancer resection — supported by randomized controlled trial evidence.

98%+
Margin Accuracy (R0)
Clear circumferential resection planes
~65%
EBL Reduction
Compared to conventional open surgery
-2.4 Days
Hospital Stay
Faster transit to adjuvant therapies
3D 10x
Nerve Sparing
High-definition micro-dissection

Evidence by Subspecialty

Filter the evidence base by clinical area

Robotic Colorectal Oncology Peer-Reviewed Protocol

Total Mesorectal Excision (TME) & Low Anterior Resections

High-definition 3D visualization and wristed instrumentation within the narrow bony pelvis allow precise dissection along embryonic avascular planes, reducing positive circumferential resection margins (CRM) and conversion rates.

Measurable Clinical Difference
  • Lower circumferential resection margin positivity (4.0% vs 7.2% in conventional laparoscopy).
  • Higher rates of sphincter preservation in mid-to-low rectal adenocarcinomas.
  • Reduction in autonomic pelvic nerve injury, preserving urinary and sexual function.
Feng Q, Yuan W, Li T, et al. (2022)
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.
The Lancet Gastroenterology & Hepatology
DOI Link
Robotic Uro-Oncology Peer-Reviewed Protocol

Nerve-Sparing Robot-Assisted Radical Prostatectomy (RARP)

Sub-millimeter dissection of the neurovascular bundles combined with tension-free vesicourethral anastomosis yields oncologic clearance equivalent to open surgery while accelerating functional restoration.

Measurable Clinical Difference
  • Equivalent 10-year biochemical recurrence-free survival in organ-confined disease.
  • Significant reduction in intraoperative blood loss and transfusion requirements (<1%).
  • Early return of urinary continence (70–85% at 3 months) and superior erectile nerve recovery.
Haglind E, Carlsson S, Stranne J, et al. (2015)
LAPPRO: A prospective multicentre study comparing robot-assisted laparoscopic and open radical prostatectomy.
The Lancet Oncology
DOI Link
Gynaecological Oncology Peer-Reviewed Protocol

Sentinel Lymph Node (SLN) Mapping & Ultra-Radical Resections

Near-infrared fluorescence imaging with Indocyanine Green (ICG) enables precise lymphotropic sentinel node identification, reducing the morbidity of full pelvic lymphadenectomy in early-stage disease.

Measurable Clinical Difference
  • Over 95% sensitivity and false-negative rates <3% for pelvic nodal metastasis in endometrial cancer.
  • Drastic reduction in lower-limb secondary lymphedema rates from ~20% to under 2%.
  • Same-day or next-day hospital discharge under Enhanced Recovery After Surgery (ERAS) protocols.
Rossi EC, Kowalski LD, Scalici J, et al. (2017)
Comparison of sentinel lymph node biopsy with full pelvic and para-aortic lymphadenectomy in endometrial cancer (FIRES): a multicentre study.
The Lancet Oncology
DOI Link
Complex Surgical Oncology Peer-Reviewed Protocol

Extended Pelvic Resections & Multi-Visceral Clearance

Multi-quadrant robotic platforms and advanced energy devices allow aggressive R0 resection margins in locally advanced tumors previously deemed non-resectable, without the morbidity of open laparotomy.

Measurable Clinical Difference
  • Maximized complete microscopic resection (R0) rates in recurrent/locally advanced pelvic tumors.
  • Shorter time to postoperative systemic adjuvant therapy (chemotherapy/immunotherapy).
  • Reduced surgical site infections (SSI) and systemic inflammatory response.
Jayne D, Pigazzi A, Marshall H, et al. (2017)
Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Conversion to Open Laparotomy (ROLARR Trial).
JAMA
DOI Link

Book Appointment

Bring your reports. Leave with a plan.

Consultations are 45 minutes. Second opinions on existing reports are welcome, in person or by teleconsultation.

Availability

Mon

10:00 – 14:00

Tue

10:00 – 13:00

Wed

Operating day

Thu

10:00 – 14:00

Fri

10:00 – 13:00

Sat

10:00 – 12:00

Request a consultation

Your information is used only to arrange your appointment. For emergencies, call +91 98557 30073.